Organelle partitioning during cell division is critical for cell growth and survival (for a review, see reference 19) . The yeast vacuole forms tubular or vesicular segregation structures during early S phase which deliver maternally derived material into the bud until late G 2 phase (3, 6) . In vitro assays which reflect the steps of in vivo inheritance were developed (3, 7) to explore the mechanisms of vacuole partition and fusion during cell division.
Segregation structures can be viewed microscopically in semi-intact cells or isolated vacuoles (3) . Formation of these structures requires ATP and cytosol and is time and temperature dependent. After structure formation, isolated vacuoles fuse and enlarge up to fivefold in diameter. This increase in size is due to vacuole-to-vacuole fusion. This fusion can also be assayed biochemically by measuring maturation of vacuolar proenzymes such as procarboxypeptidase Y or proalkaline phosphatase upon mixing of vacuole components. Homotypic fusion apparently reflects at least the last stage in vacuole segregation, whereby newly delivered vesicular material in the bud fuses into a single organelle. A quantitative colorimetric assay measuring alkaline phosphatase activity (7) has enabled more sophisticated dissection of intervacuolar fusion. This assay is performed by mixing vacuoles isolated from a pho8⌬ strain with vacuoles isolated from a pep4⌬ strain in the presence of ATP and cytosol. Upon fusion, the Pep4 proteinase (proteinase A) in the pho8⌬ vacuoles can mature pro-Pho8p (alkaline phosphatase) in the pep4⌬ vacuoles by removing the pro-peptide at the pro-Pho8p C terminus. Pho8p activity can be measured by providing a substrate, p-nitrophenyl phosphate, which turns yellow upon hydrolysis.
This quantitative assay has facilitated study of the vacuole fusion event. The effects of several pharmocological reagents have provided some insight into the types of proteins involved in fusion. Inhibition of vacuole-to-vacuole fusion by okadaic acid and microcystin suggests that type 1 and/or 2A serine/ threonine phosphatases are involved in intervacuolar fusion (3) . These types of phosphatases appear to have a role in regulation of the fungal cell cycle (1, 4) . Mutations in the PP1 gene or disruption of PP2A in Schizosaccharomyces pombe causes mitotic defects (12, 16) . The SIT4 gene encodes a PP1/PP2A-like phosphatase which plays a role in the G 1 /S phase transition in Saccharomyces cerevisiae (18) . Though okadaic acid and microcystin inhibit a wide range of phosphatases, their effects in the in vitro inheritance assay suggest that phosphorylation/ dephosphorylation events are involved. GTP-hydrolyzing proteins also appear to be important for intervacuolar fusion. Fusion can be inhibited by either mastoparans, nonhydrolyzable GTP analogs, or benzalkonium chloride (7) . Further evidence for G protein involvement is provided by studies which demonstrate that Ypt7p, a small Ras-like GTPase which is localized to the vacuole, is required for fusion (8) . In addition, an electrochemical potential is also required since CCCP, a proton ionophore, and bafilomycin, a vacuolar ATPase inhibitor, block vacuole-to-vacuole fusion (2) .
Mutants which are defective in vacuole inheritance, such as vac1-1 and vac2-1, are defective in the in vitro assay (3, 7) . The defect in these strains appears to be due to a change in the vacuoles rather than in the cytosol. Recently a new mutant, vac5-1, was characterized in vivo and the VAC5 gene was cloned and shown to be identical to PHO80 (15) . PHO80 encodes a cyclin which acts as a negative regulator of phosphate metabolism (10) . Although recessive, the vac5-1 allele of PHO80 encodes a truncated form of the cyclin which appears to be a gain-of-function mutation. This truncated form of Pho80p is missing the carboxy-terminal third of the protein, which is similar to truncations seen in other cyclins such as CLN2 and CLN3 (9, 14) . Genetic analysis demonstrates that the vac5 truncated cyclin requires its partner kinase, Pho85, and transcription factor targets, Pho4 and Pho2, to affect vacuole inheritance. In order to determine its mode of action, the vac5-1 mutant was characterized by using the in vitro assay. We now report that the cytosol of vac5-1 has a dominant negativelike defect in the in vitro assay and that this inhibitory activity is due to a small molecule.
MATERIALS AND METHODS
Yeast strains. Cytosol was prepared from derivatives of TN.2B (vac5-1 ura3-52) and TN.2C (VAC5 ura3-52) crossed into K91-A (pho8::pAL134 pho13::pPH13 ura3-52), an S. cerevisiae strain previously described by Haas et al. (7) . Vacuoles were prepared from BJ3505 (pep4::HIS3) and DKY6281 (pho8::TRP1) (7, 11) .
Microscopic and spectrophotometric vacuole fusion assays. Isolation of vacuoles and cytosol was done as previously described (3). All preparations were made from yeast cell cultures in log phase (1 ϫ 10 7 cells/ml). Cytosol was prepared by vortexing yeast cells in the presence of glass beads and buffer [20 mM piperazine-N,NЈ-bis(2-ethanesulfonic acid) (PIPES)-KOH, pH 6.8, 150 mM potassium acetate (KOAc), 0.25 M sorbitol, 5 mM magnesium acetate (Mg(OAc) 2 )]. Samples were centrifuged (3,000 ϫ g, 10 min) to remove intact cells, and the supernatant was then transferred to new tubes and centrifuged (150,000 ϫ g, 1 h, 4ЊC) to remove cell debris. When the cytosol isolated from mutant strains was cloudy, additional centrifugation was used to remove lipids. Protein was assayed by determining the A 280 . Vacuoles were isolated by lysing oxalyticase-generated yeast spheroplasts in 10 mM PIPES-KOH, pH 6.8-0.2 M sorbitol-15% Ficoll with DEAE-dextran. The lysate was then layered beneath a Ficoll density gradient (15 to 0%) and centrifuged (150,000 ϫ g, 1 h, 4ЊC). Vacuoles which floated to the 0%/4% interphase of the gradient were collected and used immediately.
The visual assay of vacuole fusion was done as previously described (3). CDCFDA-stained wild-type vacuoles isolated from BJ3505 and DKY6281 (final concentration, 0.25 mg/ml) were labeled in vitro with 50 M CDCFDA (10 min, 30ЊC) and mixed in equal proportions with cytosol at a final concentration of 2.0 mg/ml and an ATP-regenerating system (3) with 1 mM ATP. In all experiments, samples had a final volume of 30 l comprising 20 l of vacuoles, 6 l of ATP reaction buffer [final concentration, 20 mM PIPES-KOH, pH 6.8, 150 mM KOAc, 5 mM Mg(OAc) 2 , 0.3 M sorbitol, 40 mM creatine phosphate, 0.2 mg of creatine kinase per ml, 1 mM ATP], and 4 l of cytosol. Incubations were at 25ЊC for 2 h. Labeled vacuoles were viewed with a fluorescein filter (absorption wavelength 450 to 490 nm). The colorimetric assay described by Haas et al. (7) was performed as previously described and used to measure the maturation of the pro-alkaline phosphatase present in BJ3505 vacuoles.
Protease treatment of cytosol. Wild-type or vac5-1 cytosol was treated with 1.0 mg of trypsin per ml, (final concentration, 1.0 mg/ml) for 10 min at 30ЊC and incubated with a 5ϫ molar excess of trypsin inhibitor for 5 min at 30ЊC, and the mixture was added to a complete reaction of vacuoles plus ATP and incubated at 25ЊC for 2 h. Other portions of cytosol were incubated with papain bound to beads (Sigma) for 60 min at 30ЊC. Papain protease was removed by sedimenting the beads in a microcentrifuge. In each case, 45 g of treated (or untreated) wild-type or vac5-1 cytosol was added to a complete reaction with 30 g of wild-type cytosol (final total concentration of cytosol, 2.5 mg/ml). The total volume was 30 l.
Fractionation of cytosol. G25 resin was equilibrated with cytosol buffer [20 mM PIPES-KOH, pH 6.8, 150 mM KOAc, 0.25 M sorbitol, 5 mM Mg(OAc) 2 ] in 3-ml prepacked columns (Bio-Rad). The excess buffer was removed by sedimentation in a clinical centrifuge for 2 min. Cytosol (50 to 75 l) was layered on approximately 1 ml of packed resin and centrifuged for 2 min. Bradford assays were performed on the void volume fraction.
Small molecules were collected by adding cytosol at equal concentrations (15 to 20 mg/ml) to Centricon-10 ultrafiltration devices (Amicon), which are designed to allow molecules with masses of less than 10 kDa to partition to a lower chamber during centrifugation. In addition, partitioning with Centricon-3 ultrafiltration devices (with a 3-kDa cutoff) was performed, followed by fractionation with a spin column packed with G10 resin prepared as described above.
RESULTS
The in vitro inheritance assay requires three components: vacuoles, an ATP-regenerating system, and cytosol. Cytosols from vac1-1 and vac2-1 strains and from various class D vacuolar protein-sorting mutants (which have a vacuole segregation defect in vivo) are functional in the inheritance assay (3; unpublished observations). In contrast, the inability of vac5-1 components to fuse in vitro is due to an altered cytosolic component. Figures 1A and B show the microscopic assay of intervacuolar fusion in reactions with either wild-type or vac5-1 cytosol. Incubation of CDCFDA-labeled wild-type vacuoles with wildtype cytosol promotes fusion and gives rise to large vacuoles which are bigger than the starting size. In contrast, incubation with vac5-1 cytosol does not promote fusion and vacuoles either remain the same size or fragment. Defective fusion was seen with several different strain backgrounds containing the vac5-1 mutation (data not shown). Increasing amounts of wildtype cytosol, up to 2.0 mg/ml, yield a proportionately higher   FIG. 1. vac5-1 cytosol is defective in promoting vacuole-to-vacuole fusion. (A) Wild-type cytosol (2 mg/ml), 1 mM ATP, and CDCFDA-labeled wild-type vacuoles (0.25 mg/ml) were incubated at 25ЊC for 120 min. (B) CDCFDA-labeled wild-type vacuoles (0.25 mg/ml) were incubated at 25ЊC for 120 min with vac5-1 cytosol (2 mg/ml) and 1 mM ATP. (C), Concentration curve of wild-type versus vac5-1 cytosol using the pro-alkaline phosphatase maturation assay. Incubations were performed as described for panels A and B. (The value of a complete reaction from which cytosol was omitted was 0.106 U.) signal in the Pho8p maturation assay (Fig. 1C) . In contrast, vac5-1 cytosol is more active than wild-type cytosol at low concentrations (Fig. 1C) . At these lower concentrations, the vacuoles fuse normally and increase in size (data not shown). As increasing amounts of vac5-1 cytosol are added, the signal which represents vacuole fusion decreases to the level obtained in a control reaction without ATP.
The vacuole fusion obtained with 1.0-mg/ml wild-type cytosol alone ( Fig. 2A and B , WT alone) is decreased by the addition of 1.5 mg/ml vac5-1 cytosol ( Fig. 2A and B, WT ϩ A) . In contrast, additional wild-type cytosol increases the signal ( Figure 2B , WT ϩ C). Previous experiments have shown that trypsin pretreatment of wild-type cytosol inhibits the ability of the cytosolic components to promote intervacuolar fusion (3).
This suggests that at least some of the cytosolic components required for fusion are proteinaceous. Protease digests were performed to determine whether the vac5-1 inhibitory factor is proteinaceous. Pretreatment with either trypsin or papain did not affect the ability of vac5-1 cytosol to inhibit the activity of wild-type cytosol ( Fig. 2A and B, WT ϩ B) . In control reactions, the same protease treatment of wild-type cytosol did not yield inhibitory activity (Fig. 2A, WT ϩ C, and 2B, WT ϩ D) . The signal obtained in these controls is approximately the same as those obtained in reactions with wild-type cytosol alone. Separate assays showed that the proteases were active.
To determine whether the inhibition is reversible, wild-type vacuoles were preincubated with vac5-1 cytosol and then reisolated for a second incubation with wild-type cytosol (Fig. 3) . Exposure of wild-type vacuoles to wild-type cytosol and ATP during the first 0 to 30 min did not affect their ability to fuse (Fig. 3A) . The control aliquots, transferred to ice at the indicated times, show the amount of fusion achieved in the first incubation. Maximal signals were obtained if wild-type cytosol was added in the second incubation. Addition of vac5-1 cytosol in the second incubation had the greatest inhibitory effect at the earlier time points. In contrast to the wild-type control, preincubation with vac5-1 cytosol plus ATP for only 15 min irreversibly inactivated the wild-type vacuoles (Fig. 3B) .
Since protease treatment did not abolish the inhibitory activity of vac5-1 cytosol (Fig. 2B) , partial fractionation was performed to determine the size of the vac5-1 factor. vac5-1 cytosol was separated into a protein fraction and a smallmolecule fraction by using Sephadex G25 gel filtration and an ultrafiltration membrane with a cutoff at 10 kDa (see Materials and Methods). The activity of the G25 void volume fraction was variable but was always less than the activity of unfractionated cytosol (data not shown). Figure 4A shows the effects of adding back the small-molecule fraction (mass, Ͻ10 kDa) from wild-type cytosol or vac5-1 cytosol to a complete fusion reaction with the vac5-1 protein fraction. The first two bars represent signals obtained with wild-type (dots) or vac5-1 (hatched) G25 protein fractions alone. As more wild-type small molecules are added to vac5-1 proteins, the signal increases and reaches a plateau. In contrast, as more vac5-1 small molecules are added to vac5-1 proteins, the signal rises initially and then decreases, similar to the pattern obtained with unfractionated vac5-1 cytosol (Fig. 1C) . The inhibition by the vac5-1 smallmolecule fraction is maximal at 4 l, a volume which corresponds to the volume of unfractionated vac5-1 cytosol required for comparable inhibition.
Further size fractionation of vac5-1 small molecules demonstrates that the vac5-1 factor is bigger than 0.7 kDa and smaller than 3.0 kDa. vac5-1 cytosol was first passed through an ultrafiltration membrane with a cutoff at 3 kDa, and the filtrate was then passed through G10 resin to remove small ions and molecules. Figure 4B shows the results of adding either wild-type or vac5-1 small molecules (C3/G10 fractions; masses between 3.0 and 0.7 kDa) to wild-type G25 void volume proteins. The wild-type small-molecule fraction still stimulates the fusion activity of the protein fraction, whereas the vac5-1 small molecule fraction inhibits activity.
DISCUSSION
The in vitro inheritance assay measures intervacuolar fusion, a late step in the vacuole segregation process, and vac5-1 cytosol is defective in promoting this step. In vivo, many vac5-1 mutant cells exhibit single, round mother cell vacuoles without either segregation structures or vacuolar material in the bud (15) . If stained with fluoroscein isothiocyanate, many mutant Wild-type or vac5-1 cytosol was incubated with trypsin (final concentration, 1 mg/ml) for 10 min at 30ЊC. Trypsin inhibitor was then added (5 min at 30ЊC), and the mixture was incubated with a complete reaction of wild-type vacuoles and ATP and 1-mg/ml wild-type untreated cytosol for 2 h at 25ЊC. (B) Treatment of vac5-1 cytosol with papain does not remove inhibitory activity. Wild-type or vac5-1 cytosol was incubated for 60 min at 30ЊC with papain anchored to beads. The beads were sedimented, and the supernatant was then added to a complete reaction as described for panel A. In each experiment, 1.5 mg of protease-treated (or untreated) cytosol per ml as well as 1 mg of untreated cytosol per ml, was added to the incubations with vacuoles and ATP. The background of 0.394 U from incubations with ATP but no cytosol was subtracted.
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vac5-1 CYTOSOLIC INHIBITOR 4049 cells display buds which contain a single small vesicle. Taken together, these cytological observations suggest that mutant cells either do not form vacuolar segregation structures or only manage to partition a small amount of material to the bud. This is consistent with our in vitro findings that isolated wildtype vacuoles, if incubated with vac5-1 cytosol, either remain the same size or tend to fragment (Fig. 1) . Concentration curves of vac5-1 cytosol reveal an interesting pattern of fusion activity that is greater than wild-type activity at low concentrations and inactive at high concentrations. This suggests that a factor which normally promotes fusion is present at higher levels in vac5-1 cytosol. Too much of this factor may inhibit intervacuolar fusion in the same way that adding too much wild-type cytosol can inhibit fusion. If one adds a final concentration of 4 mg/ml or more of wild-type cytosol to a complete reaction, then fusion activity starts to decrease (6a). In addition, excess stimulatory factor may en-
FIG. 3. Rapid inactivation of vacuoles by vac5-1 cytosol. (A)
A complete reaction of wild-type cytosol, ATP, and vacuoles was performed at 25ЊC. Aliquots were removed, and the vacuoles were sedimented (10,000 ϫ g, 1 min, 4ЊC) and resuspended to the same concentration in isolation buffer (0.2 M sorbitol, 10 mM PIPES-KOH, pH 6.8). These samples were divided into three aliquots, and a second incubation was performed with the indicated cytosols plus ATP for a total of 120 min (the third aliquot was immediately placed on ice). (B) A complete reaction of vac5-1 cytosol, ATP, and vacuoles was prepared and treated as described for panel A .   FIG. 4 . Size of the vac5-1 factor. (A) Fractionation of vac5-1 cytosol reveals that the cytosolic inhibitor is a small molecule. A wild-type or vac5-1 smallmolecule fraction obtained by ultrafiltration with a Centricon-10 filter (Ͻ10-kDa cutoff) was added to a vac5-1 G25 void volume fraction containing proteins and molecules of Ͼ3 kDa (1 mg/ml) and assayed in the presence of ATP and vacuoles. The total volume of each reaction was 30 l. The first two bars compare fusion activity of wild-type (dots) and vac5-1 (wide hatch) G25-purified proteins alone. (B) The cytosol from wild-type and vac5-1 cells was fractionated by passage through a Centricon-3 filter (Ͻ3 kDa cutoff) and applied to G10 resin spin columns (0.7-kDa cutoff). The void volume from the G10 resin was added to the G25 void volume protein fraction of wild-type cytosol (1 mg/ml). The first bar (dots) indicates the signal obtained with wild-type G25 proteins alone. Samples were incubated with wild-type vacuoles and ATP at 25ЊC for 2 h. The assay value of a complete reaction from which cytosol was omitted (for panel A, 0.190; for panel B, 0.269) was subtracted from each.
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able vac5-1 to inhibit the activity of wild-type cytosol. Alternatively, vac5-1 may induce the expression of a distinct inhibitor, although this model is not consistent with the observation that vac5-1 cytosol has higher-than-normal activity at low concentrations. Partial fractionation and protease treatment of vac5-1 cytosol suggests that the vac5-1 factor is a small, protease-resistant molecule with a size of between 0.7 and 3 kDa. These results suggest that the vac5-1 factor is neither a small polypeptide nor a small ion. The vac5-1 inhibitory factor(s) appears to be an overproduced component normally involved in fusion. Since metabolic phosphatase (e.g., Pho5) expression increases in vac5-1 strains, it seemed possible that an increase in phosphate might have been the cause of inhibition of vacuolar membrane fusion. However, this is very unlikely, since the fractionation with G10 resin removes most of the P i . Furthermore, the amount of P i that is present in the 3.0-to 0.7-kDa, vac5-1 small-molecule fraction as measured by a malachite green assay is too low to account for an inhibitory effect in the vacuole fusion assay (unpublished observations).
The requirement for small molecules other than peptides or ions has been shown in other reconstituted systems measuring membrane fusion. One example is palmityl-coenzyme A, which stimulates N-ethylmaleimide-sensitive factor-dependent cis Golgi to trans Golgi fusion (5, 17) . A second example is arachidonic acid, which has an annexin-dependent role in endosome fusion (13) . The present study provides an assay for the purification of the small molecule which is overproduced in vac5-1 strains. This is an essential step towards evaluating its function in the regulation of vacuole inheritance.
